| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 55 |
| 1 | ASPIRIN 325 MG | 54 |
| 2 | ASPIRIN 81 MG | 54 |
| 3 | RIVAROXABAN | 47 |
| 4 | APIXABAN | 41 |
| 5 | PREDNISONE | 35 |
| 6 | ADALIMUMAB | 33 |
| 7 | CLOPIDOGREL | 29 |
| 8 | METHOTREXATE SODIUM | 29 |
| 9 | BEVACIZUMAB | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUCIZUMAB | 5 | 0.0035 |
| 1 | IOHEXOL | 18 | 0.0021 |
| 2 | ARGATROBAN | 3 | 0.0020 |
| 3 | ALMOTRIPTAN | 2 | 0.0019 |
| 4 | ATROPINE SULFATE INJECTION | 4 | 0.0016 |
| 5 | ATROPINE SULFATE MONOHYDRATE | 4 | 0.0016 |
| 6 | AMIKACIN SULFATE | 2 | 0.0011 |
| 7 | EDOXABAN TOSYLATE | 6 | 0.0009 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 7 | 0.0008 |
| 9 | AMPICILLIN SODIUM AND SULBACTAM SODIUM | 2 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 101 |
| 1 | Factor Xa Inhibitor [EPC] | 88 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 86 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 58 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 32 |
| 5 | Proton Pump Inhibitor [EPC] | 30 |
| 6 | Loop Diuretic [EPC] | 29 |
| 7 | Benzodiazepine [EPC] | 28 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 28 |
| 9 | Osmotic Laxative [EPC] | 28 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Humanized Monoclonal Antibody Fragment [EPC] | 5 | 0.0035 |
| 1 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Anti-coagulant [EPC] | 4 | 0.0011 |
| 3 | Vitamin D2 Analog [EPC] | 6 | 0.0008 |
| 4 | Radiographic Contrast Agent [EPC] | 21 | 0.0008 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 7 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 8 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 9 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |